Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Thomas Jackson currently holds 20,000 shares of Spero Therapeutics, Inc. (SPRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Thomas Jackson has been a net buyer of SPRO stock. They have purchased $57.6K and sold $0 worth of shares.
Scott Thomas Jackson's most recent insider trade was on Jun 23, 2026, when they sold 20,000 shares at $0.00 per share.
Scott Thomas Jackson serves as Executive at Spero Therapeutics, Inc. (SPRO). They have executed 21 insider transactions totaling $57.6K over their tenure at the company.
Scott Thomas Jackson holds the position of Executive at Spero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Scott Thomas Jackson has shown a buying trading pattern, with $57.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Thomas Jackson was on Jul 12, 2016, when they sold $9.1M worth of CPXX shares. This transaction involved 301,518 shares at $30.25 per share.
Scott Thomas Jackson currently owns 20,000 shares of Spero Therapeutics, Inc. (SPRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Thomas Jackson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Thomas Jackson has 21 Form 4 filings on record as an insider at Spero Therapeutics, Inc..
Set alerts for Scott Thomas Jackson and 40,000+ other insiders.